Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.
Douglas M Herrin, Emily E Coates, Pamela J Costner...
https://pubmed.ncbi.nlm.nih.gov/25483691/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-16
500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying immune responses to vaccines and natural infections by collecting tissue and blood samples from adults aged 18 years and older. This observational research aims to improve understanding of how the immune system protects against diseases and to support development of immunological tests and vaccines. Participants include healthy adults who have received FDA-approved vaccines, investigational vaccines, or recovered from infections, with data collected for research purposes rather than treatment. Participants may provide various samples such as blood through regular draws or apheresis, urine, saliva, semen, vaginal swabs, tissue biopsies, and undergo imaging like PET or CT scans. Some may also have procedures like bronchoscopy, gastrointestinal endoscopy, or colonoscopy for tissue collection. These procedures are optional and depend on the specific research questions being addressed. The study allows flexible sample donation frequency as guided by protocol and institutional policies. During the study, participants will undergo clinical assessments and provide specimens voluntarily, with imaging and tissue sampling guided by ultrasound when needed. Researchers will analyze immune responses in blood, body fluids, and tissues throughout the study, which usually lasts up to one year. Participants will receive compensation, and the study follows ethical review and safety guidelines to protect participants well-being.
CONDITIONS
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
O
OPS Team, VRC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit
Duration - Up to 1 year
Participants provide blood, tissue, body fluid samples, and may undergo imaging or procedures such as endoscopy to collect tissue samples. Participation in each procedure is voluntary and depends on the research needs.
Visits as needed for sample collection and evaluations
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Douglas M Herrin, Emily E Coates, Pamela J Costner...
https://pubmed.ncbi.nlm.nih.gov/25483691/Jens Wrammert, Joe Miller, Rama Akondy...
https://pubmed.ncbi.nlm.nih.gov/19052852/Troy D Querec, Rama S Akondy, Eva K Lee...
https://pubmed.ncbi.nlm.nih.gov/19029902/Stanley A Plotkin
https://pubmed.ncbi.nlm.nih.gov/19793898/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor